So, whats changed
In October, Tirzepatide was removed from the shortage list, a decision the FDA said it will update by Thursday
Therefore, clinicians should check in on patients mental well-being throughout treatment
This causes painful symptoms related to the location of this tissue, such as pelvic pain, painful periods (dysmenorrhea), painful sex (dyspareunia), painful urination (dysuria), diarrhoea and infertility, among others
Potential Exploratory Directions in Other Digestive System Diseases Beyond the aforementioned major areas, this drug has shown preliminary potential in other digestive system disorders
10.1016/j.taap.2020.115110 137 WangW.GreenM.ChoiJ